February 1, 2025 Accelerating Parkinson’s Disease Drug Development with Federated Learning Approaches Parkinson’s Disease is a progressive neurodegenerative disorder afflicting almost 12 million people...
February 13, 2025 Breaking the silence: challenges and opportunities in pediatric drug development Pediatric drug development faces significant challenges, including underfunding, ethical concerns, and complex regulatory...
February 1, 2025 Increased discoverability of rare disease datasets through knowledge graph integration Healthcare datasets can be used for many different purposes in the pursuit of...
January 7, 2025 Inclusion in neurological research: empowering people living with neurological diseases The value of involving people living with diseases in the research process is increasingly recognized...
December 13, 2024 Real-world evidence in the cloud: Tutorial on developing an end-to-end data and analytics pipeline using Amazon Web Services resources In the rapidly evolving landscape of healthcare and drug development, the ability to efficiently collect...
November 27, 2024 Voice of the Patient report Externally-Led Patient-Focused Drug Development (EL-PFDD) Meeting for ARPKD Patients and their Families Autosomal Recessive Polycystic Kidney Disease (ARPKD) is a rare genetic disease. It occurs in about one in 20,000 births...
November 27, 2024 Autosomal Recessive Polycystic Kidney Disease (ARPKD)Adjunct EL-PFDD Scientific Workshop Report The mission of the Polycystic Kidney Disease Foundation is to fund research, advocate for patients, and ultimately to end PKD..
December 12, 2024 Investigating item response theory model performance in the context of evaluating clinical outcome assessments in clinical trials Item response theory (IRT) models are an increasingly popular method choice for...
November 27, 2024 A computational tool to optimize clinical trial parameter selection in Duchenne muscular dystrophy: A practical guide and case studies Duchenne muscular dystrophy (DMD), a rare pediatric disease, presents numerous challenges when designing clinical trials...
December 1, 2024 Advancing rare disease measurement through the Rare Disease Clinical Outcome Assessment Consortium Naomi Knoble, and Lindsey T. Murray on behalf of the Rare Disease Clinical Outcome Assessment Consortium. View all authors and aff